@article{goirand:hal-01936325,
TITLE = {How can we best monitor 5-FU administration to maximize benefit to risk ratio?},
AUTHOR = {Goirand, Fran{\c c}oise and Lemaitre, Florian and Launay, Manon and Tron, Camille and Chatelut, Etienne and Boyer, Jean-Christophe and Bardou, Marc and Schmitt, Antonin},
URL = {https://univ-rennes.hal.science/hal-01936325},
JOURNAL = {Expert Opinion on Drug Metabolism and Toxicology},
PUBLISHER = {Taylor \& Francis},
VOLUME = {14},
NUMBER = {12},
PAGES = {1303-1313},
YEAR = {2018},
MONTH = Dec, DOI = {10.1080/17425255.2018.1550484},
KEYWORDS = {5-fluorouracil ; colorectal cancer ; head and neck (HandN) cancer ; pharmacokinetics ; therapeutic drug monitoring (TDM)},
PDF = {https://univ-rennes.hal.science/hal-01936325/file/How%20can%20we%20best%20monitor%205FU%20administration_accepted.pdf},
HAL_ID = {hal-01936325},
HAL_VERSION = {v1},
}